Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (5351)	7/17/1998 7:36:00 PM
From: John Zwiener	Respond to of 9719

I take it the Cabot recommendation is a nonevent, though I have talked to some that say overall, they are good. Anyway, I don't follow analysts (though I think this time they got it right). Today it was noted Whiterock Capital continues to buy shares during June at prices up to over 37 dollars. The letter Sepracor sent to doctors made a very positive impression and patients will be switched to levalbuterol as it comes available. There is interest in Aviron flumist with pediatricians, especially for children with asthma and otitis media, and their siblings.